Location History:
- Gilbert, IA (US) (2013)
- Ames, IA (US) (2023)
Company Filing History:
Years Active: 2013-2023
Title: Vellareddy Anantharam: Innovator in Neurotherapeutics
Introduction
Vellareddy Anantharam is a notable inventor based in Gilbert, Iowa. He has made significant contributions to the field of neurotherapeutics, particularly in the diagnosis and treatment of neurological diseases. With a total of 2 patents, his work focuses on innovative solutions for complex medical challenges.
Latest Patents
Anantharam's latest patents include groundbreaking research in the area of Parkinson's disease. His first patent, titled "Nano-theranostics for Parkinson's disease," provides aggregate alpha-synuclein specific antibodies, along with their fragments, derivatives, and variants. This invention aims to facilitate early diagnosis and treatment of Parkinson's Disease and related conditions. The patent also discloses assays, kits, systems, and nanoparticle encapsulated compositions related to these antibodies.
The second patent, "Design, synthesis and functional characterization of rottlerin analogs," describes a novel method for synthesizing rottlerin analogs from commercially available materials. This method is the first of its kind and aims to produce cost-effective analogs. The patent further details the structures of these analogs and their potential applications in treating neurological or inflammatory responses mediated by protein kinase C (PKC).
Career Highlights
Vellareddy Anantharam is affiliated with the Iowa State University Research Foundation, Inc., where he continues to advance his research. His work has garnered attention for its potential impact on the treatment of neurological disorders.
Collaborations
Anantharam has collaborated with esteemed colleagues, including Anumantha G Kanthasamy and Balaji Narasimhan, to further his research endeavors.
Conclusion
Vellareddy Anantharam's innovative contributions to neurotherapeutics highlight his commitment to improving the diagnosis and treatment of neurological diseases. His patents reflect a dedication to advancing medical science and enhancing patient care.